Randomised clinical trial: effects of MD-7246 on irritable bowel syndrome with diarrhoea.
Alimentary pharmacology & therapeutics（2023）
Abstract
MD-7246 at the doses studied did not improve abdominal pain relative to placebo in an IBS-D patient population. Similarly, most additional efficacy endpoints showed no improvement with MD-7246 relative to placebo.
MoreTranslated text
Key words
irritable bowel syndrome,diarrhoea,clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined